Focus on innovation and lead repair: Jiangsu Cmall Biotechnology made a stunning appearance at the medical exhibition, and the hydrocolloid dressing attracted much attention

[Shanghai, China, October 26, 2024] In the golden October of October, the 85th China International Medical Equipment (Autumn) Expo (CMEF) grandly opened at the Shanghai National Convention and Exhibition Center. At this largest medical technology feast in the Asia-Pacific region, Jiangsu Cmall Biotechnology Co., Ltd. (hereinafter referred to as "Cmall Biotechnology") became a shining star at the exhibition with its innovative achievements in the field of high-end wound care - "Yushu" series of hydrocolloid medical dressings, demonstrating to global merchants the strong strength of China's intelligent manufacturing in the field of biomedical materials.

Star products are unveiled to redefine the new wound care experience

In the carefully arranged exhibition area of Cmall Biotechnology, there is an endless stream of professional visitors who come to consult and experience. The core exhibit, the Cmall series of hydrocolloid medical dressings, has solved many pain points of traditional dressings with its excellent performance and humanized design, and has attracted widespread attention.

The company’s senior product manager introduced at the scene: “Hydrocolloid technology is known as the ‘breathing dressing art’. The core of our product lies in its unique ‘hydrocolloid polymer matrix’ structure. It can actively absorb wound exudate and form a soft gel-like substance, creating a ‘moist healing’ for the wound. An ideal environment. A large number of clinical studies have shown that wet healing can significantly accelerate epithelial cell migration and increase wound healing by up to 30% to 50%.

Compared with traditional gauze dressings, Cmall's hydrocolloid dressings have multiple advantages:

Painless replacement: The gel formed after absorbing exudate does not adhere to new granulation tissue, avoiding the pain of "secondary tearing" during replacement, greatly improving patient comfort.

Effective Waterproof: Excellent sealing performance not only prevents external bacteria and moisture from intruding, but also allows patients to take a short shower without affecting normal life.

 Invisible beauty: The ultra-thin, skin-colored, and highly elastic design can perfectly fit the skin and joints, like a "second layer of skin", taking into account functionality and aesthetics.

Technology is the cornerstone and innovation is the engine, demonstrating the core strength of the enterprise

Behind the "Cmall" series of products is Cmall Biotechnology's strong R&D and manufacturing capabilities accumulated over more than ten years of deep involvement in the field of biomaterials. The company is located in Jiangsu High-tech Industrial Park. It has an automated production line with a 10,000-level cleanliness level and strictly implements the ISO 13485 medical device quality management system to ensure that every dressing delivered from the factory is of reliable quality.

The R&D director of Cmall Biotech emphasized at the technology sharing meeting: "We are not just producing a dressing, but also carefully carving a microenvironment that promotes healing. We started from the molecular level and conducted thousands of experiments and optimizations on the particle size of the hydrocolloid sodium carboxymethylcellulose (CMC) particles, the mixing ratio, and the moisture permeability rate of the backing material. Finally, we achieved a perfect balance between absorption performance, viscosity, and breathability. This is the core technical barrier of Cmall products."

In addition, the company also exhibited special dressings for different clinical scenarios, such as thickened hydrocolloids suitable for joints such as heels and elbows, and foam dressings designed for chronic wounds such as diabetic feet and pressure ulcers, which fully demonstrated its ability to provide integrated wound care solutions guided by clinical needs.

Connect the global market and create a national medical device brand

During the exhibition, Cmall Bio's booth became a hub for international cooperation. Buyers and partners from Europe, Southeast Asia, the Middle East and other places showed strong interest in the "Yushu" series of products, and many institutions reached preliminary agency cooperation intentions on the spot.

Mr. Yang, the general manager of the company, said: "Participating in top industry exhibitions such as CMEF is a key step in Cmall Biotech's 'going global' strategy. We hope that through this platform, we will not only bring our high-quality products to global users, but also hope to show the world that Chinese medical device companies are no longer just 'manufacturing' He is an ‘innovator’ with core technologies. In the future, Cmall Biotech will continue to increase investment in research and development, with the mission of ‘focusing on repair and focusing on experience’, and is committed to becoming the world’s leading provider of innovative wound care solutions, so that high-quality medical products made in China can benefit more patients.”

The success of this exhibition has pressed the accelerator button for the development of Taizhou Cmall Biotechnology Co., Ltd. (CMallBio), and also indicates that it will write a more glorious chapter in its journey to the global high-end dressing market.